https://retina.news.mail.ru/prev780x440/pic/cc/7f/main41658513_5b4d88327f2c25914c0bd3412e072b84.jpg

two groups of scientists were able to identify in laboratory conditions, antibodies capable of neutralizing coronavirus, SARS-CoV-2. The day before, 4 may, about a successful laboratory experiment reported by a group of scientists from the Netherlands, whose article was published in the journal Nature. Today, may 5, it became known about creation of antibodies to coronavirus in a scientific laboratory Institute for biological research Israel (IIBR). This was during press-conference said the defense Minister Naftali Bennett, according to Reuters.

In both cases we are talking about the selection of monoclonal antibodies that attack the virus by destroying its protein thorn, through which the virus enters the cells of the human body. The resulting antibodies neutralize SARS-CoV-2, preventing it from spreading.

Both groups of scientists called the results of the tests are a breakthrough, because in theory, these antibodies are unable to cope with the pandemic COVID-19 and help prevent the epidemic of coronavirus infections in the future. While scientists emphasize that in order to confirm the effectiveness of the obtained antibodies it is necessary to test on animals and clinical trials in humans.

the defense Minister of Israel Naftali Bennett said that Israeli scientists have provided him with his development during his yesterday’s visit to the IBR. Experts said that the development stage of the antibodies complete, but they are still in need of “thorough testing”. Now the IIBR laboratory must begin testing on humans. After that, the Israeli scientists hope to negotiate with international companies on the production of antibodies “in commercial quantities”, according to Israeli portal i24.

In April, the world health organization has published a list of 83 the development of promising vaccines against COVID-19. The list includes nine Russian developments. In March, Russian scientists succeeded in decoding the full genome of the virus that can speed up the appearance of the vaccine. In Russia, clinical trials could begin on 1 June. In the US develop 14 vaccines against coronavirus. American President Donald trump is sure to create a vaccine in the country until the end of the year.

Kirill Saranac, Laura Keffer